PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 2, 2006, Pages 512-517

  Ciezki, Jay P ^a   Reddy, Chandana A ^a   Garcia, Jorge ^a   Angermeier, Kenneth ^a   Ulchaker, James ^a   Mahadevan, Arul ^a   Chehade, Nabil ^b   Altman, Andrew ^b   Klein, Eric A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Prostate brachytherapy; Prostate cancer; PSA bounce phenomenon; PSA kinetics

Indexed keywords

ENZYME KINETICS; ONCOLOGY; PATIENT TREATMENT; RADIOTHERAPY; REGRESSION ANALYSIS;

PROSTATE CANCER; PSA BOUNCE PHENOMENON; PSA KINETICS;

ANTIGENS;

ANDROGEN; IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BRACHYTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; KINETICS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 30544454901     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.07.960     Document Type: Article

References (14)

1. F.A. Vicini, A. Martinez, G. Hanks An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up Cancer 95 2002 2126 2135
2. J.P. Ciezki, E.A. Klein, K. Angermeier A retrospective comparison of the use of androgen deprivation among low- and intermediate-risk prostate cancer patients treated with brachytherapy, external-beam radiotherapy, or radical prostatectomy Int J Radiat Oncol Biol Phys 60 2004 1347 1350
3. C. Patel, M.A. Elshaikh, K. Angermeier PSA bounce predicts early success in patients with permanent iodine-125 prostate implant Urology 63 2004 110 113
4. S. Nag, D. Beyer, J. Friedland American Brachytherapy Society (ABS) recommendations for transperineal placement brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 1999 789 799
5. K. Angermeier, J.P. Ciezki Brachytherapy management of prostate cancer 2004 Humana Press Totowa, NJ 329 339
6. J. Cox, D. Grignon, R. Kaplan Consensus statement Guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1997 1035 1041
7. E.M. Horwitz, H.D. Thames, D.A. Kuban Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone A multi-institutional pooled analysis J Urol 173 2005 797 802
8. R.G. Stock, N.N. Stone, J.A. Cesaretti Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer Descriptions and implications Int J Radiat Oncol Biol Phys 56 2003 448 453
9. A.V. D'Amico, J.W. Moul, P.R. Carroll Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy J Natl Cancer Institute 95 2003 1376 1383
10. M.J. Zelefsky, L. Ben-Porat, H.I. Scher Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer J Clin Oncol 23 2005 826 831
11. C.R. Pound, A.W. Partin, M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1642 1645
12. A.F. Prestigiacomo, T.A. Stamey Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers J Urol 155 1996 1977 1980
13. A.L. Zeitman, J.P. Christodouleas, W.U. Shipley PSA bounces after neoadjuvant androgen deprivation and external-beam radiation Impact on definitions of failure Int J Radiat Oncol Biol Phys 62 2005 714 718
14. P.A. Kupelian, J.C. Buchsbaum, M.A. Elshaikh Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy Year of treatment an independent predictor of outcome Int J Radiat Oncol Biol Phys 57 2003 629 634